Zhang Xiaofeng,MD
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Early Phase I Study of Autologous T Cells (EX02 CAR-T) for Unresectable Pancreatic/Bile Duct Cancer (NCT06196658) | Zhang Xiaofeng,MD | 2024-01-01 |
| Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for H. Pylori Infection (TATH-1) (NCT05647278) | Zhang Xiaofeng,MD | 2023-11-01 |
| Canagliflozin With Gemcitabine in Pancreatic Carcinoma (NCT05903703) | Zhang Xiaofeng,MD | 2023-10-01 |
| Comparison of Oral Lactulose Versus Polyethylene Glycol for Bowel Preparation in Low-risk Patients (NCT05648318) | Zhang Xiaofeng,MD | 2022-01-08 |
Track Zhang Xiaofeng,MD automatically
Every clearance here is in the API, with alerts when new ones post.